کپسول
بوعلی دارو
Figharalin Booali Daroo Capsule®
30 capsules 780 mg
Ingredients:
Valeriana sisymbriifolia, Crocus sativus, Commipora opobalsamum, Aloe vera, Cinnamomum zeylanicum, Asarum europaeum, Pistacia lentiscus
Dosage:
Adults should take two capsules with one glass of warm water each night before sleeping. Teenagers aged between 12-18 years old should take one capsule each night with a glass of warm water.
Indications:
Treatment of constipation, Stomach laxative, cleansing wastes from the stomach and head
Storage conditions:
Keep away from light, moisture and at temperatures below 30°C.
Recommended Precautions:
Short-term usage may lead to gastrointestinal and rash complications.
It is contraindicated during pregnancy, breastfeeding, in children under the age of 12 years old, patients with obstruction, colitis, intestinal disorders and any acute gastrointestinal illness, severe dehydration, nephritis, coagulation disorders and if any allergy to any of the ingredients of the product existed.
It may interfere with the effects of digoxin, thiazide diuretics, corticosteroids, quinidine, antiplatelet drugs and anticoagulants.
Consult with a physician or pharmacist if you have thyrotoxicosis or the drug needs to be co-administered with other laxatives.
Drug therapeutic effects:
mumiayi Booali Daroo Capsule is a combination of mineral MUMY, acacia nilotica, rock candy and rose water used to treat weakness of the body and bone traumas. Because the mineral MUMY has been prescribed in most traditional medicine sources for bone traumas and fractures, it has been named MUMY. MUMY has been used in traditional medicine to treat inflammation, joint damage, fractures, dislocations, contusion, ulcers and spinal pain and its beneficial effects have been earlier mentioned in Avicenna’s book (Al Qanun Fil Tibb) . Validated books on traditional medicine and clinical and laboratory studies showed the therapeutic effects of MUMY. A study investigated the effect of MUMY on healing of tibial and femoral bones in patients who were referred to Shahrekord hospital. At the baseline, patients’ pain severity was measured using the VAS scale, then the patients were divided into two groups of MUMY recipients and conventional drug recipients. Results of radiological performance assessment after the study showed a significant difference in treatment group compared to the control group (P<0.05). In addition, the pain severity was lower in the case group than in the control group, by passing one week from treatment .
In another study, the effect of MUMY was investigated on the bone tissue of alcohol-treated rats. Rats were divided into 6 groups, including the first group as control, the second group was receiving MUMY (100 mg / kg day), the third group was receiving MUMY (200 mg / kg day), the fourth group was receiving 30% alcohol and MUMY (100 mg / kg), the fifth group was receiving 30% alcohol and mumy (200 mg / kg) and the sixth group was receiving 30% alcohol for 10 weeks. Then, bone mechanical strength, bone weight, liver antioxidant enzymes and alkaline phosphatase were evaluated. The results showed that MUMY was effective in reducing liver enzymes and preserving bone health. In addition, studies have shown a positive effect of mumy on sex hormones. In a clinical study, the effect of mumy on testosterone levels was investigated. In this study, 90 patients were divided into mumy and placebo recipient groups. The treatment group received mumy (250 mg twice a day) for 90 days. The results showed a significant increase in testosterone levels, also the FSH and LH levels remained unchanged.